Teacher Retirement System of Texas lifted its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 32.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,305 shares of the company's stock after purchasing an additional 15,120 shares during the period. Teacher Retirement System of Texas owned about 0.06% of Encompass Health worth $6,209,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock worth $960,817,000 after buying an additional 138,196 shares in the last quarter. Invesco Ltd. lifted its holdings in Encompass Health by 3.3% in the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company's stock valued at $511,273,000 after acquiring an additional 176,135 shares during the last quarter. Alliancebernstein L.P. lifted its stake in Encompass Health by 6.0% during the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock worth $191,799,000 after purchasing an additional 117,617 shares in the last quarter. FMR LLC raised its stake in shares of Encompass Health by 0.8% in the fourth quarter. FMR LLC now owns 1,973,846 shares of the company's stock valued at $182,285,000 after acquiring an additional 15,831 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Encompass Health by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock valued at $155,176,000 after acquiring an additional 6,164 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.
Encompass Health Stock Performance
Shares of NYSE EHC traded up $0.18 during midday trading on Monday, reaching $119.22. 647,780 shares of the company were exchanged, compared to its average volume of 702,366. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. Encompass Health Corporation has a 1 year low of $82.74 and a 1 year high of $123.13. The stock has a fifty day simple moving average of $119.39 and a 200 day simple moving average of $105.53. The stock has a market cap of $12.02 billion, a P/E ratio of 24.63, a PEG ratio of 2.42 and a beta of 0.88.
Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The firm's revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.12 earnings per share. On average, research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.
Encompass Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.57%. Encompass Health's payout ratio is 14.05%.
Insider Activity
In other news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president directly owned 79,710 shares in the company, valued at approximately $9,149,910.90. This trade represents a 11.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the sale, the chief executive officer owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 132,663 shares of company stock worth $16,034,082. Company insiders own 2.10% of the company's stock.
Analyst Ratings Changes
Several analysts have recently issued reports on the company. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Barclays raised their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Royal Bank Of Canada raised their price target on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Finally, Truist Financial restated a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Eight research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $127.00.
Check Out Our Latest Research Report on EHC
About Encompass Health
(
Free Report)
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Articles
Before you consider Encompass Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.
While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
